News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
128 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (29193)
Month
January (2935)
February (2968)
March (2707)
April (2905)
May (3623)
June (2409)
July (2086)
August (2588)
September (2381)
October (3062)
November (1529)
Day
1 (150)
2 (125)
3 (95)
5 (29)
6 (105)
7 (106)
8 (131)
9 (140)
10 (84)
13 (72)
14 (99)
15 (146)
16 (136)
17 (106)
19 (47)
20 (160)
21 (173)
22 (150)
23 (143)
24 (76)
26 (1)
27 (133)
28 (187)
29 (138)
30 (128)
31 (202)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
31
Earnings
Zepbound Topples Sales King Keytruda as Lilly Reports 54% YoY Revenue Rise for Q3
Mounjaro and Zepbound contributed more than $10 billion to the $11.98 billion in sales Lilly recorded for key products in the third quarter, despite price decreases for the GLP-1 medicines.
October 30, 2025
·
1 min read
·
Annalee Armstrong
Earnings
Lilly Walks Pricing Tightrope With Upcoming Weight Loss Pill Orforglipron
CEO David Ricks wants Eli Lilly’s upcoming obesity pill to be accessible to patients who need it, but the company still needs to pay for the next generation of obesity medicines to come after that.
October 30, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
October 30, 2025
·
9 min read
Press Releases
Vaxil Announces Non-Brokered Private Placement
October 30, 2025
·
3 min read
Press Releases
Bausch Health Announces Third Quarter 2025 Results
October 30, 2025
·
52 min read
Press Releases
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF
October 30, 2025
·
10 min read
Press Releases
Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
October 30, 2025
·
11 min read
Press Releases
Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results
October 30, 2025
·
13 min read
Press Releases
TransMedics Reports Third Quarter 2025 Financial Results
October 30, 2025
·
11 min read
Press Releases
STERIS Announces Dividend of $0.63 per share
October 30, 2025
·
4 min read
Previous
2 of 13
Next
